Roles of Immunity and Endogenous Retroelements in the Pathogenesis of Rheumatoid Arthritis and Treatment Strategies
- PMID: 40205241
- DOI: 10.1007/s10142-025-01583-4
Roles of Immunity and Endogenous Retroelements in the Pathogenesis of Rheumatoid Arthritis and Treatment Strategies
Abstract
Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease that primarily affects the joints. RA usually results in synovial hyperplasia, expansion of "pannus" and destruction of cartilage. The etiology and pathogenesis of RA are not fully understood, but immunity has been shown to play an important role in the development of autoimmune diseases such as RA. In addition, endogenous retroelements, the remnants of ancient retroviruses in the human genome, are involved in cancer and/or immune disorders. As evidenced by increasing evidences that the aberrant expression of retroelements induces innate immunity, despite the fact that the expression of most retroelements has been epigenetically suppressed over a long period of evolution. With the continuous development of disease-modifying anti-rheumatic drugs (DMARDs), RA disease activity has been alleviated and improved. Unfortunately, some patients have a limited response to DMARDs, and the drugs also have the disadvantages of some side effects and high economic costs. This review summarizes the pathogenic mechanisms of RA and endogenous retroelements in autoimmunity, and concludes with a summary of treatments for RA, along with new therapeutic recommendations.
Keywords: Adaptive immunity; Anti-rheumatic drugs; Autoimmune disease; Endogenous retroelements; Innate immunity; Rheumatoid arthritis.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis.Int J Mol Sci. 2020 Nov 28;21(23):9067. doi: 10.3390/ijms21239067. Int J Mol Sci. 2020. PMID: 33260629 Free PMC article. Review.
-
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis.Cells. 2020 Apr 3;9(4):880. doi: 10.3390/cells9040880. Cells. 2020. PMID: 32260219 Free PMC article. Review.
-
One year in review 2018: pathogenesis of rheumatoid arthritis.Clin Exp Rheumatol. 2018 Mar-Apr;36(2):175-184. Epub 2018 Apr 18. Clin Exp Rheumatol. 2018. PMID: 29716677 Review.
-
One year in review 2016: pathogenesis of rheumatoid arthritis.Clin Exp Rheumatol. 2016 Sep-Oct;34(5):793-801. Epub 2016 Sep 16. Clin Exp Rheumatol. 2016. PMID: 27716458 Review.
-
Biologic agents in rheumatoid arthritis: an update for managed care professionals.J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S14-8. doi: 10.18553/jmcp.2011.17.s9-b.S14. J Manag Care Pharm. 2011. PMID: 22073935 Free PMC article. Review.
References
-
- Alex AM, Kunkel G, Sayles H, Flautero Arcos JD, Mikuls TR, Kerr GS (2020) Exposure to ambient air pollution and autoantibody status in rheumatoid arthritis. Clin Rheumatol 39:761–768. https://doi.org/10.1007/s10067-019-04813-w - DOI - PubMed
-
- Arango Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5. https://doi.org/10.3389/fimmu.2014.00491 - DOI - PubMed - PMC
-
- Arason GJ, Jorgensen GH, Ludviksson BR (2010) Primary immunodeficiency and autoimmunity: lessons from human diseases. Scand J Immunol 71:317–328. https://doi.org/10.1111/j.1365-3083.2010.02386.x - DOI - PubMed
-
- Ardura JA, Rackov G, Izquierdo E, Alonso V, Gortazar AR, Escribese MM (2019) Targeting macrophages: friends or foes in disease? Front Pharmacol 10. https://doi.org/10.3389/fphar.2019.01255 - DOI - PubMed - PMC
-
- Babaian A, Mager DL (2016) Endogenous retroviral promoter exaptation in human cancer. Mob DNA 7:21. https://doi.org/10.1186/s13100-016-0080-x - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials